About
Respiratory antiviral therapies
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Team (3)
Brett P
Brett P. Giroir, MDChief Executive OfficerFull BioFormer US Assistant Secretary for Health and Admiral, US Public Health Service,Former Acting FDA Commissioner
Altesa BioSciences
team_member
James F
James F. Donohue, MDFull BioFormer Professor of Medicine, Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel HillRecipient of the “Breathing for Life...
Altesa BioSciences
team_member
Karen Fusaro
Karen FusaroSenior Vice PresidentClinical DevelopmentFull Bio25+ years designing clinical trialsExpertise spans from large global pharmaceutical companies to small biotechs specializing in infectious...
Altesa BioSciences
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
81
By Phase
PHASE1/PHASE2: 1PHASE2: 1PHASE1: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06834295Lead Sponsor
A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]Vapendavir
PHASE1/PHASE2Completed
8 participants
Started: Mar 12, 2025 · Completed: Mar 23, 2025
NCT06149494Lead Sponsor
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
PHASE2Completed
52 participants
Started: Nov 20, 2023 · Completed: Mar 30, 2025
NCT05962645Lead Sponsor
Phase 1 Study Into Pharmacokinetics and Food Effect of Vapendavir in Healthy Participants and Participants With COPD
PHASE1Completed
21 participants
Started: May 19, 2023 · Completed: May 2, 2024
Locations (1)
Headquarters
College Park, GA, United States
Map
Loading map...